Literature DB >> 29803821

Rise of multidrug-resistant Streptococcus pneumoniae clones expressing non-vaccine serotypes among children following introduction of the 10-valent pneumococcal conjugate vaccine in Bulgaria.

L Setchanova1, A Alexandrova2, D Pencheva3, I Sirakov2, K Mihova3, R Kaneva3, I Mitov2.   

Abstract

OBJECTIVES: Pneumococcal conjugate vaccines (PCVs) have reduced the incidence of pneumococcal disease, but non-vaccine serotypes are of concern, particularly if antimicrobial-resistant. This study retrospectively evaluated the serotype-specific clonality of paediatric multidrug-resistant (MDR) invasive and non-invasive Streptococcus pneumoniae isolates collected following PCV10 introduction (2011-2017) in Bulgaria.
METHODS: Capsular types, drug resistance patterns and multilocus sequence typing (MLST) of the most common MDR S. pneumoniae serotypes sampled from children were determined.
RESULTS: Overall, the rate of MDR pneumococci was 44.6% (107/240). The most common serotypes among MDR strains were 19F (25.2%), 19A (19.6%), 6C (13.1%), 6A and 23A (6.5% each) and 15A (4.7%), contributing 75.7% of all MDR strains. With the exception of serotype 19F, the remaining serotypes were non-PCV10 types. Among MDR pneumococci, the most frequently found sequence types were ST320 (30.4%; 19A and 19F), ST386 (12.7%; 6C and 6A) and ST8029 (5.1%; 23A). The majority of MDR STs (74.7%) belonged to PMEN clonal complexes, of which the most common were CC320 (Taiwan19F-14), CC315 (Poland6B-20) and CC180 (Netherlands3-31), accounting for 43.0%, 13.9% and 5.1%, respectively. In the post-vaccine period, a shift in the genetic structure of serotype 19A was found, with a significant increase of PMEN-14 (CC320) and a concurrent decrease of the major clone Denmark14-32 (CC230) observed prior to PCV10 introduction in Bulgaria.
CONCLUSIONS: Clonality was found behind the wide distribution of MDR capsular types 19A, 6C, 23A and 3 following vaccine introduction, and a highly multiresistant and virulent clone Taiwan19F-14/ST320 has emerged as a common pathogen in children.
Copyright © 2018 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  MLST; Multidrug resistance; Non-vaccine serotypes; PCV10; Streptococcus pneumoniae

Mesh:

Substances:

Year:  2018        PMID: 29803821     DOI: 10.1016/j.jgar.2018.05.012

Source DB:  PubMed          Journal:  J Glob Antimicrob Resist        ISSN: 2213-7165            Impact factor:   4.035


  4 in total

1.  Emergence of Streptococcus pneumoniae serotype 19A (Spn19A) in the pediatric population in Bogotá, Colombia as the main cause of invasive pneumococcal disease after the introduction of PCV10.

Authors:  Germán Camacho Moreno; Luisa F Imbachi; Aura L Leal; Vivian M Moreno; Jaime A Patiño; Iván F Gutiérrez; Sandra Beltrán; Martha I Álvarez-Olmos; Cristina Mariño; Rocío Barrero; Fabio Espinosa; Nicolás Ramos; Liliana P Castellar; Nella Sánchez; Anita Montañez
Journal:  Hum Vaccin Immunother       Date:  2020-02-20       Impact factor: 3.452

2.  Application of next generation sequencing-based rapid detection platform for microbiological diagnosis and drug resistance prediction in acute lower respiratory infection.

Authors:  Lingshan Chao; Jihong Li; Ya'nan Zhang; Hao Pu; Xixin Yan
Journal:  Ann Transl Med       Date:  2020-12

3.  Serotype Distribution and Antibiotic Susceptibility of Streptococcus pneumoniae Isolates in Tehran, Iran: A Surveillance Study.

Authors:  Soheila Habibi Ghahfarokhi; Mehrdad Mosadegh; Ali Ahmadi; Mohammad Reza Pourmand; Mohammad Azarsa; Mohammad Rahbar; Bahram Nikmanesh
Journal:  Infect Drug Resist       Date:  2020-02-04       Impact factor: 4.003

4.  Genomic surveillance of invasive Streptococcus pneumoniae isolates in the period pre-PCV10 and post-PCV10 introduction in Brazil.

Authors:  Samanta C G Almeida; Stephanie W Lo; Paulina A Hawkins; Rebecca A Gladstone; Ana Paula Cassiolato; Keith P Klugman; Robert F Breiman; Stephen D Bentley; Lesley McGee; Maria-Cristina de C Brandileone
Journal:  Microb Genom       Date:  2021-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.